NAUTNautilus Biotechnology, Inc.

$289M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$76M

Total Liabilities

$5M

Stockholders' Equity

$72M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$2M	-$3M	+40.6%
Net Income	-$2M	-$3M	+39.7%

NAUT Q1 2021 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena